Clinical Trial

A Taiwan-Adapted Self-Management Program for Adults With Irritable Bowel Syndrome

Study acronym: CSM-T-IBS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This pilot randomized controlled trial will evaluate the feasibility, acceptability, and preliminary effects of a Taiwanese version of a comprehensive self-management program for adults with irritable bowel syndrome. Participants will be randomized to the self-management program or usual care. Outcomes will be assessed at baseline, immediately after the intervention, and three months after the intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-05.
Trial Details
NCT Number NCT07693907
Lead Sponsor National Defense Medical Center, Taiwan
Collaborators: Tri-Service General Hospital (TSGH), National Health Research Institutes, Taiwan
Conditions Irritable Bowel Syndrome
Enrollment 54 participants
Start Date 2026-07-15
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-07-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-15